About LigaChem Biosciences
LigaChem Biosciences is a Healthcare company. LigaChem Biosciences is focused on developing innovative drugs for unmet medical needs. It operates on a Professional Services and Licensing Model model. LigaChem Biosciences offers products and services including ADC Platform and Small Molecule Drugs. Its focus areas include Biotechnology and Oncology.
Company details
LigaChem Biosciences is engaged in the research and development of innovative drugs, particularly in the fields of antibody-drug conjugates (ADC) and small molecule therapies. The company is dedicated to addressing unmet medical needs through next-generation cancer treatments and immune-oncology solutions. Partnerships with global entities are leveraged to accelerate drug development. Operations are centered in the biotechnology and pharmaceutical sectors with a commitment to sustainable leadership through ESG initiatives.
- SectorsHealthcare
- Website legochembio.com
Products & Services of LigaChem Biosciences
LigaChem Biosciences offers a comprehensive portfolio of products and services, including ADC Platform and Small Molecule Drugs.
Next-generation antibody-drug conjugates are developed for cancer treatment.
Innovative small molecule therapies are created for oncology.
People of LigaChem Biosciences
14 people are tracked at LigaChem Biosciences (9 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Young Lag Cho | Chief Development Officer | Leadership |
Yong Zu Kim | CEO & President | Leadership |
Sejin Park | Chief Financial Officer & Vice President | Leadership |
YongSoo Yoon | Marketing Director | Leadership |
YeongSoo Oh | Executive VP & CTO | Leadership |
Chul-Woong Chung | CTO | Leadership |
Jeiwook Chae | Chief Business Development Officer | Leadership |
Sook Kyung Chang | Director | Leadership |
Jaseong Koo | Head of CMC Center | Leadership |
Yun Hee Park | 이사급 연구위원 | Team |
현진 배 | Senior Research Scientist | Team |
KWANG HWA JUNG | Team Leader, Senior Ressearch Scientist II | Team |
Keon Woo Kwon | Senior Researcher | Team |
Dong Yeon Shin | Principal Research Scientist/ Development Strategy Team | Team |
Complete people profiles for LigaChem Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of LigaChem Biosciences
Websites that share an audience with LigaChem Biosciences (legochembio.com).
Websites whose visitors overlap most with LigaChem Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ligachembio.com | 100% | 11.1K | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LigaChem Biosciences
LigaChem Biosciences is engaged in the research and development of innovative drugs, particularly in the fields of antibody-drug conjugates (ADC) and small molecule therapies. The company is dedicated to addressing unmet medical needs through next-generation cancer treatments and immune-oncology solutions. Partnerships with global entities are leveraged to accelerate drug development. Operations are centered in the biotechnology and pharmaceutical sectors with a commitment to sustainable leadership through ESG initiatives.
LigaChem Biosciences offers ADC Platform and Small Molecule Drugs.